<?xml version="1.0" encoding="utf-8"?>
<doi_batch xmlns="http://www.crossref.org/schema/4.3.6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" version="4.3.6" xsi:schemaLocation="http://www.crossref.org/schema/4.3.6 https://www.crossref.org/schemas/crossref4.3.6.xsd">
  <head>
    <doi_batch_id>_1568958446</doi_batch_id>
    <timestamp>1568958446</timestamp>
    <depositor>
      <depositor_name>Editor</depositor_name>
      <email_address>editor.jddt@gmail.com</email_address>
    </depositor>
    <registrant>UJPR</registrant>
  </head>
  <body>
    <journal>
      <journal_metadata>
        <full_title>Universal Journal of Pharmaceutical Research</full_title>
        <abbrev_title>Univ J Pharm Res</abbrev_title>
        <issn media_type="electronic">2456-8058</issn>
      </journal_metadata>
      <journal_issue>
        <publication_date media_type="online">
          <month>04</month>
          <day>11</day>
          <year>2018</year>
        </publication_date>
      </journal_issue>
      <journal_article xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" publication_type="full_text" metadata_distribution_opts="any">
        <titles>
          <title>ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF OMEPRAZOLE AND ASPIRIN USING REVERSE PHASE HPLC METHOD IN BULK AND DOSAGE FORM</title>
        </titles>
        <contributors>
          <person_name contributor_role="author" sequence="first">
            <given_name>Vani</given_name>
            <surname>R</surname>
          </person_name>
          <person_name contributor_role="author" sequence="first">
            <given_name>Sunitha</given_name>
            <surname>M</surname>
          </person_name>
        </contributors>
        <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1">
          <jats:p>A new simple, accurate, precise and reproducible RP-HPLC method has been developed for the simultaneous estimation of Aspirin and Omeprazole in bulk and pharmaceutical dosage form using C18 column (Agilent, 250 x 4.6 mm, 5 μm) in isocratic mode. The mobile phase consisted of Methanol and 0.1 M Dipotassium Phosphate buffer (pH 3) in the ratio of 60:40 v/v. The detection was carried out at 256 nm. The method was linear over the concentration range for Omeprazole 50-250 μg/ml and for Aspirin 10-50 μg/ml. The recoveries of Omeprazole and Aspirin were found to be 100.07 and 100.06% respectively. The validation of method was carried out utilizing ICH-guidelines. The described HPLC method was successfully employed for the analysis of pharmaceutical formulations containing combined dosage form.&#13;
Google Scholar</jats:p>
        </jats:abstract>
        <publication_date media_type="online">
          <month>07</month>
          <day>01</day>
          <year>2017</year>
        </publication_date>
        <doi_data>
          <doi>10.22270/ujpr.v2i4.R6</doi>
          <resource>http://ujpr.org/index.php/journal/article/view/68</resource>
          <collection property="crawler-based">
            <item crawler="iParadigms">
              <resource>http://ujpr.org/index.php/journal/article/download/68/52</resource>
            </item>
          </collection>
          <collection property="crawler-based">
            <item crawler="iParadigms">
              <resource>http://ujpr.org/index.php/journal/article/download/68/237</resource>
            </item>
          </collection>
          <collection property="text-mining">
            <item>
              <resource mime_type="application/pdf">http://ujpr.org/index.php/journal/article/download/68/52</resource>
            </item>
            <item>
              <resource mime_type="text/html">http://ujpr.org/index.php/journal/article/download/68/237</resource>
            </item>
          </collection>
        </doi_data>
      </journal_article>
    </journal>
  </body>
</doi_batch>
